Healthcare Industry News: Biovail
News Release - July 19, 2006
TriPath Imaging, Inc. Announces Promotions of Johnny D. Powers, Ph.D. to President, TriPath Oncology and James D. Petrilla to Senior Vice President, Commercial OperationsBURLINGTON, N.C., July 19 (HSMN NewsFeed) -- TriPath Imaging, Inc. (Nasdaq: TPTH ), announced today that Johnny D. Powers, Ph.D., the Company's Senior Vice President and General Manager, TriPath Oncology has been promoted to President, TriPath Oncology and that James D. Petrilla, the Company's Vice President, Worldwide Marketing and Customer Training, has been promoted to Senior Vice President, Commercial Operations. Ray W. Swanson has resigned his position as Senior Vice President, Commercial Operations and will leave the Company to pursue other interests.
"I would like to congratulate Johnny Powers and Jim Petrilla on their well-deserved promotions, and I look forward to working with them in their expanded roles," said Paul R. Sohmer, M.D., Chairman, President and CEO of TriPath Imaging, Inc. "I would also like to thank Ray Swanson for his many contributions since joining the Company in 2001."
Dr. Powers will continue to lead the TriPath Oncology business unit and will also assume leadership of the Company's manufacturing and quality assurance functions. He joined TriPath Imaging in October 2001 upon appointment as Vice President of Manufacturing Operations. In July 2002, he was promoted to Senior Vice President and General Manager, TriPath Oncology, the Company's wholly-owned subsidiary that is developing molecular diagnostic products for cancers of the cervix, breast, ovary and prostate. Prior to joining TriPath Imaging, Dr. Powers served as Vice President and General Manager of Manufacturing Operations, Vice President and General Manager of Worldwide Strategic Marketing, and Vice President of Molecular Diagnostic Systems Business Unit at Ventana Medical Systems, Inc.
In his new role, Mr. Petrilla will assume leadership of the Company's cervical cancer screening business. Mr. Petrilla joined the Company in January 2006 as Vice President, Worldwide Marketing and Customer Training. Prior to joining TriPath Imaging, Mr. Petrilla served as President and CEO of StemCo Biomedical, Inc., Vice President and General Manager of the Biovail Corporation, and Vice President, Global Brand Champion (Chairman of Full Development Team), General Manager (VP) Anti-Virals Europe, Vice President, National Accounts, and Vice President, Managed Care Sales-East Area at the Bristol-Meyers Squibb Company. Mr. Petrilla is a graduate of the United States Naval Academy.
TriPath Imaging, Inc., headquartered in Burlington, North Carolina, develops, manufactures, markets and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging and treatment. TriPath Oncology, a wholly-owned subsidiary of TriPath Imaging, develops molecular diagnostic products for malignant melanoma and cancers of the cervix, breast, ovary and prostate. For more information on TriPath Imaging please visit our web site at www.tripathimaging.com.
Source: TriPath Imaging
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.